Tissue Biomarkers for Diagnosis & Management of Oral Squamous Cell Carcinoma

Alpha Omegan

Volumn 100, Issue 4, 2007, Pages 182-189

  D'Silva, Nisha J ^a   Ward, Brent B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; ECONOMICS; HEALTH CARE COST; HUMAN; MASS SCREENING; MOUTH TUMOR; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; HEALTH CARE COSTS; HUMANS; MASS SCREENING; MOUTH NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 40749112683     PISSN: 00026417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aodf.2007.10.014     Document Type: Article

References (91)

1. Modjtahedi H. Molecular therapy of head and neck cancer. Cancer Metastasis Rev 24 (2005) 129-146
2. Todd R., Donoff R.B., and Wong D.T. The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 55 (1997) 613-623 discussion 623-5
3. Bsoul S.A., Huber M.A., and Terezhalmy G.T. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract 6 (2005) 1-16
4. Altschuler D.L., Peterson S.N., Ostrowski M.C., and Lapetina E.G. Cyclic AMP-dependent activation of Rap1b. J Biol Chem 270 (1995) 10373-10376
5. Myers J.N., Greenberg J.S., Mo V., and Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92 (2001) 3030-3036
6. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., Lee B., Rolnitzky L., Hille J.J., Genden E., Urken M.L., and Wang B.Y. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29 (2005) 167-178
7. Goldberg H.I., Lockwood S.A., Wyatt S.W., and Crossett L.S. Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer 74 (1994) 565-572
8. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
9. Lewin F., Norell S.E., Johansson H., Gustavsson P., Wennerberg J., Biorklund A., and Rutqvist L.E. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82 (1998) 1367-1375
10. Ames B.N., and Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249 (1990) 970-971
11. Mao L., Hong W.K., and Papadimitrakopoulou V.A. Focus on head and neck cancer. Cancer Cell 5 (2004) 311-316
12. Decker J., and Goldstein J.C. Risk factors in head and neck cancer. N Engl J Med 306 (1982) 1151-1155
13. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 467-475
14. Forastiere A.A., Trotti A., Pfister D.G., and Grandis J.R. Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24 (2006) 2603-2605
15. Fakhry C., and Gillison M.L. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24 (2006) 2606-2611
16. Hansson B.G., Rosenquist K., Antonsson A., Wennerberg J., Schildt E.B., Bladstrom A., and Andersson G. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125 (2005) 1337-1344
17. Kjaer S.K., Chackerian B., van den Brule A.J., Svare E.I., Paull G., Walbomers J.M., Schiller J.T., Bock J.E., Sherman M.E., Lowy D.R., and Meijer C.L. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10 (2001) 101-106
18. Boy S., Van Rensburg E.J., Engelbrecht S., Dreyer L., van Heerden M., and van Heerden W. HPV detection in primary intra-oral squamous cell carcinomas-commensal, aetiological agent or contamination?. J Oral Pathol Med 35 (2006) 86-90
19. Miller C.S., and Johnstone B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 622-635
20. Cianfriglia F., Di Gregorio D.A., Cianfriglia C., Marandino F., Perrone Donnorso R., and Vocaturo A. Incidence of human papillomavirus infection in oral leukoplakia. Indications for a viral aetiology. J Exp Clin Cancer Res 25 (2006) 21-28
21. Kansky A.A., Seme K., Maver P.J., Luzar B., Gale N., and Poljak M. Human papillomaviruses (HPV) in tissue specimens of oral squamous cell papillomas and normal oral mucosa. Anticancer Res 26 (2006) 3197-3201
22. Smith E.M., Ritchie J.M., Summersgill K.F., Klussmann J.P., Lee J.H., Wang D., Haugen T.H., and Turek L.P. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108 (2004) 766-772
23. Maden C., Beckmann A.M., Thomas D.B., McKnight B., Sherman K.J., Ashley R.L., Corey L., and Daling J.R. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 135 (1992) 1093-1102
24. Gallagher R.P., and Lee T.K. Adverse effects of ultraviolet radiation: a brief review. Prog Biophys Mol Biol 92 (2006) 119-131
25. Pogoda J.M., and Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control 7 (1996) 458-463
26. Perez-Ordonez B., Beauchemin M., and Jordan R.C. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59 (2006) 445-453
27. Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. Oral and Maxillofacial Pathology. 2nd edition (2002), Ed. W. B. Saunders
28. Nemeth Z., Velich N., Bogdan S., Ujpal M., Szabo G., and Suba Z.S. The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors. Neoplasma 52 (2005) 95-102
29. Ephros H., and Mashberg A. Toluidine blue-viewpoints. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 (1999) 526-527 author reply 528-9
30. Shiboski C.H., Shiboski S.C., and Silverman Jr. S. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28 (2000) 249-256
31. Cancer, S. American Cancer Society. http://www.cancer.org/docroot/pro/content/pro_1_1_Cancer_Statistics_2004_presentation.asp Accessed April 1, 2007
32. Thomas G.R., Nadiminti H., and Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86 (2005) 347-363
33. El-Mofty S.K., and Lu D.W. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27 (2003) 1463-1470
34. Byers R.M., Bland K., Borlase B., and Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 136 (1978) 525-528
35. Jones A.S. Prognosis in mouth cancer: tumour factors. Eur J Cancer B Oral Oncol 30B (1994) 8-15
36. Loree T.R., and Strong E.W. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160 (1990) 410-414
37. Sieczka E., Datta R., Singh A., Loree T., Rigual N., Orner J., and Hicks Jr. W. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control?. Am J Otolaryngol 22 (2001) 395-399
38. Sawair F.A., Irwin C.R., Gordon D.J., Leonard A.G., Stephenson M., and Napier S.S. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 32 (2003) 1-9
39. Bryne M., Koppang H.S., Lilleng R., Stene T., Bang G., and Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 18 (1989) 432-437
40. Bryne M., Boysen M., Alfsen C.G., Abeler V.M., Sudbo J., Nesland J.M., Kristensen G.B., Piffko J., and Bankfalvi A. The invasive front of carcinomas. The most important area for tumour prognosis?. Anticancer Res 18 (1998) 4757-4764
41. O'Brien C.J., Smith J.W., Soong S.J., Urist M.M., and Maddox W.A. Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence, and survival. Am J Surg 152 (1986) 456-463
42. Tytor M., and Olofsson J. Prognostic factors in oral cavity carcinomas. Acta Otolaryngol Suppl 492 (1992) 75-78
43. Mamelle G., Pampurik J., Luboinski B., Lancar R., Lusinchi A., and Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 168 (1994) 494-498
44. Woolgar J.A., Scott J., Vaughan E.D., Brown J.S., West C.R., and Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl 77 (1995) 325-331
45. Brizel D.M., and Esclamado R. Concurrent chemoradiotherapy for locally advanced, nometastatic, squamous carcinoma of the head and neck: consensus, controvery, and conundrum. J Clin Oncol 24 (2006) 2612-2617
46. Massano J., Regateiro F.S., Januario G., and Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 67-76
47. O'Brien C.J., Lauer C.S., Fredricks S., Clifford A.R., McNeil E.B., Bagia J.S., and Koulmandas C. Tumor thickness influences prognosis of T1 and T2 oral cavity cancer-but what thickness?. Head Neck 25 (2003) 937-945
48. O-charoenrat P., Pillai G., Patel S., Fisher C., Archer D., Eccles S., and Rhys-Evans P. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 39 (2003) 386-390
49. Warburton G., Nikitakis N.G., Roberson P., Marinos N.J., Wu T., Sauk Jr. J.J., Ord R.A., and Wahl S.M. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 65 (2007) 475-484
50. Spiro R.H., Huvos A.G., Wong G.Y., Spiro J.D., Gnecco C.A., and Strong E.W. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 152 (1986) 345-350
51. Cianfriglia F., Di Gregorio D.A., and Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 35 (1999) 157-163
52. Ganly I., and Kaye S.B. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects. Ann Oncol 11 (2000) 11-16
53. Adelstein D.J., and Leblanc M. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?. J Clin Oncol 24 (2006) 2624-2628
54. Clark L.J., Edington K., Swan I.R., McLay K.A., Newlands W.J., Wills L.C., Young H.A., Johnston P.W., Mitchell R., Robertson G., et al. The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Br J Cancer 68 (1993) 617-620
55. Jordan R.C., and Daley T. Oral squamous cell carcinoma: new insights. J Can Dent Assoc 63 (1997) 517-518 521-5
56. Saranath D., Chang S.E., Bhoite L.T., Panchal R.G., Kerr I.B., Mehta A.R., Johnson N.W., and Deo M.G. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63 (1991) 573-578
57. Kalyankrishna S., and Grandis J.R. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24 (2006) 2666-2672
58. Bettendorf O., Piffko J., and Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?. Oral Oncol 40 (2004) 110-119
59. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., Jones C.U., Sur R., Raben D., Jassem J., Ove R., Kies M.S., Baselga J., Youssoufian H., Amellal N., Rowinsky E.K., and Ang K.K. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
60. Motokura T., and Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 3 (1993) 5-10
61. Shintani S., Nakahara Y., Mihara M., Ueyama Y., and Matsumura T. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 37 (2001) 498-504
62. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
63. Namazie A., Alavi S., Olopade O.I., Pauletti G., Aghamohammadi N., Aghamohammadi M., Gornbein J.A., Calcaterra T.C., Slamon D.J., Wang M.B., and Srivatsan E.S. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112 (2002) 472-481
64. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 (2000) 256-263
65. Nogueira C.P., Dolan R.W., Gooey J., Byahatti S., Vaughan C.W., Fuleihan N.S., Grillone G., Baker E., and Domanowski G. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope 108 (1998) 345-350
66. Edstrom S., Cvetkovska E., Westin T., and Young C. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Laryngoscope 111 (2001) 124-130
67. Kerkela E., and Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12 (2003) 109-125
68. Stetler-Stevenson W.G., Aznavoorian S., and Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9 (1993) 541-573
69. Emonard H.P., Remacle A.G., Noel A.C., Grimaud J.A., Stetler-Stevenson W.G., and Foidart J.M. Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res 52 (1992) 5845-5848
70. Katayama A., Bandoh N., Kishibe K., Takahara M., Ogino T., Nonaka S., and Harabuchi Y. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10 (2004) 634-640
71. Jordan R.C., Macabeo-Ong M., Shiboski C.H., Dekker N., Ginzinger D.G., Wong D.T., and Schmidt B.L. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10 (2004) 6460-6465
72. Zhou X., Temam S., Oh M., Pungpravat N., Huang B.L., Mao L., and Wong D.T. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8 (2006) 925-932
73. van Hinsbergh V.W., Engelse M.A., and Quax P.H. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26 (2006) 716-728
74. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Brandsma J., Sasaki C., Joe J., Camp R.L., Rimm D.L., and Psyrri A. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24 (2006) 736-747
75. Schwartz S.R., Yueh B., McDougall J.K., Daling J.R., and Schwartz S.M. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125 (2001) 1-9
76. Lindel K., Beer K.T., Laissue J., Greiner R.H., and Aebersold D.M. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92 (2001) 805-813
77. Mellin H., Friesland S., Lewensohn R., Dalianis T., and Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89 (2000) 300-304
78. Mellin Dahlstrand H., Lindquist D., Bjornestal L., Ohlsson A., Dalianis T., Munck-Wikland E., and Elmberger G. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 25 (2005) 4375-4383
79. Itoh S., Matsui K., Furuta I., and Takano Y. Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol 39 (2003) 829-835
80. Neufeld G., Cohen T., Gitay-Goren H., Poltorak Z., Tessler S., Sharon R., Gengrinovitch S., and Levi B.Z. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev 15 (1996) 153-158
81. O-charoenrat P., Rhys-Evans P., and Eccles S.A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92 (2001) 556-568
82. Teknos T.N., Cox C., Yoo S., Chepeha D.B., Wolf G.T., Bradford C.R., Carey T.E., and Fisher S.G. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 24 (2002) 1004-1011
83. Mashberg A. Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration. Oral Oncol 36 (2000) 253-255
84. Epstein J.B., Oakley C., Millner A., Emerton S., van der Meij E., and Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 537-547
85. Mashberg A., and Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 45 (1995) 328-351
86. Wang C.Y., Chiang H.K., Chen C.T., Chiang C.P., Kuo Y.S., and Chow S.N. Diagnosis of oral cancer by light-induced autofluorescence spectroscopy using double excitation wavelengths. Oral Oncol 35 (1999) 144-150
87. Betz C.S., Mehlmann M., Rick K., Stepp H., Grevers G., Baumgartner R., and Leunig A. Autofluorescence imaging and spectroscopy of normal and malignant mucosa in patients with head and neck cancer. Lasers Surg Med 25 (1999) 323-334
88. Potter T.J., Summerlin D.J., and Campbell J.H. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg 61 (2003) 674-677
89. Potter T.J., Summerlin D.J., Campbell J.H., and Tomich C.E. The oral brush biopsy: a step forward?. J West Soc Periodontol Periodontal Abstr 50 (2002) 69-70
90. Slater L.J. Oral brush biopsy: false positives redux. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 419
91. Huber M.A., Bsoul S.A., and Terezhalmy G.T. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 35 (2004) 378-384